Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Retained Earnings (2020 - 2025)

PROCEPT BioRobotics has reported Retained Earnings over the past 6 years, most recently at -$641.6 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$641.6 million for Q4 2025, down 17.51% from a year ago — trailing twelve months through Dec 2025 was -$641.6 million (down 17.51% YoY), and the annual figure for FY2025 was -$641.6 million, down 17.51%.
  • Retained Earnings for Q4 2025 was -$641.6 million at PROCEPT BioRobotics, down from $42000.0 in the prior quarter.
  • Over the last five years, Retained Earnings for PRCT hit a ceiling of $84000.0 in Q4 2023 and a floor of -$641.6 million in Q4 2025.
  • Median Retained Earnings over the past 5 years was -$348.8 million (2022), compared with a mean of -$337.1 million.
  • Biggest five-year swings in Retained Earnings: soared 1500.0% in 2023 and later plummeted 8435816.67% in 2024.
  • PROCEPT BioRobotics' Retained Earnings stood at -$261.5 million in 2021, then surged by 100.0% to -$6000.0 in 2022, then soared by 1500.0% to $84000.0 in 2023, then crashed by 650082.14% to -$546.0 million in 2024, then dropped by 17.51% to -$641.6 million in 2025.
  • The last three reported values for Retained Earnings were -$641.6 million (Q4 2025), $42000.0 (Q3 2025), and -$590.3 million (Q2 2025) per Business Quant data.